Description
LL-37 | Human Cathelicidin Peptide for Research
Â
We offer high-purity LL-37, the 37-amino acid C-terminal fragment of the human cathelicidin antimicrobial protein (hCAP18). As a key component of the innate immune system, this peptide is supplied in a lyophilized form to ensure maximum stability and bioactivity for immunology and microbiology research.
LL-37 is a cationic, amphipathic peptide that is a fundamental tool for scientists studying host defense mechanisms. It is used extensively in in-vitro models to investigate microbial membrane interactions, chemotaxis, and immunomodulatory effects on various cell types. Its well-characterized properties make it essential for research into innate immunity, inflammation signaling, and the development of novel research reagents.
Â
Important Notice & Disclaimer
Â
This product is intended for laboratory research purposes only. It is not a food, drug, or cosmetic and is not intended for human or veterinary consumption. By purchasing this product, you agree that you are a qualified researcher or scientist and are purchasing it for in-vitro laboratory use. Any other use is strictly forbidden. Please handle this product in a properly equipped laboratory, using all necessary safety precautions.
Â
LL-37 Properties
Â
-
Source: PubChem (CID: 16132442)
-
Form: Lyophilized powder
-
Unit size: 1mg/vial
-
Unit quantity: 1 vial
-
Bottle: Vial – Flip top – Sealed
-
Vial size: 3ml
-
Molecular formula:
-
Molecular weight: 4493.3 g/mol
-
Sequence: Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser
-
CAS number: 204537-83-3
Â
Storage and Handling
Â
For optimal integrity, it is recommended to store lyophilized LL-37 in a freezer at -20°C. Once reconstituted, the peptide solution should be stored in a refrigerator at 2-8°C and used within a short timeframe. For longer-term storage, aliquot and freeze at -20°C or -80°C. Avoid repeated freeze-thaw cycles.

Reviews
There are no reviews yet.